We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

21 hedge funds and large institutions have $2.46M invested in Coeptis Therapeutics Warrants in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $1.84M → $2.46M (+$628K)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

5% more funds holding

Funds holding: 20 → 21 (+1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
3
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$5.32K
2
Citadel Advisors
Citadel Advisors
Florida
+$920

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$208K
2
AA
AQR Arbitrage
Connecticut
-$21.6K
3
CAC
Cowen and Company
New York
-$21K
4
ICM
Ionic Capital Management
New York
-$3.25K
5
Walleye Capital
Walleye Capital
New York
-$47

COEPW Hedge Fund Activity: Q4 2021 in Review

21 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2021, worth a combined $2.46M — up 34% from $1.84M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new COEPW positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $5.32K. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $208K sold.

  • 21 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2021, up from 20 in Q3 2021.
  • Funds reported $2.46M of Coeptis Therapeutics Warrants stock for Q4 2021, up 34% quarter-over-quarter.
  • 4 funds opened new Coeptis Therapeutics Warrants positions in Q4 2021 and 3 closed out, a net change of +1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q4 2021 was Virtu Financial, an estimated $5.32K added.
  • The largest Coeptis Therapeutics Warrants seller in Q4 2021 was Glazer Capital LLC, an estimated $208K sold.

Based on aggregated 13F filings for Q4 2021.